Barclays
GMO

Barclays’s General Moly, Inc. GMO Stock Holding History

Barclays’s Portfolio GMO Stock Details GMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-800
Closed – – 5808
2020
Q2 		$0 Buy
+800
New +$158 ﹤0.01% 6517
2019
Q3 		– Sell
-67
Closed – – 7359
2019
Q2 		$0 Buy
+67
New +$19 ﹤0.01% 7484
2018
Q2 		– Sell
-2
Closed – – 7461
2018
Q1 		$0 Buy
+2
New +$1 ﹤0.01% 7486
2014
Q3 		– Sell
-18,602
Closed -$18.2K – 7896
2014
Q2 		$18K Buy
18,602
+16,348
+725% +$17.1K ﹤0.01% 6578
2014
Q1 		$0 Sell
2,254
-4,763
-68% -$5.78K ﹤0.01% 7788
2013
Q4 		$7K Buy
7,017
+6,445
+1,127% +$9.25K ﹤0.01% 7105
2013
Q3 		$1K Sell
572
-10,790
-95% -$19.5K ﹤0.01% 7328
2013
Q2 		$21K Buy
+11,362
New +$22.4K ﹤0.01% 6821

Other funds holding GMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Barclays's GMO Position: Q3 2020 in Review

Barclays sold out of General Moly, Inc. (GMO) in Q3 2020, closing a stake of 800 shares.

Barclays first reported a position in GMO in Q2 2013 and held it in 8 quarters. The position peaked at $21K in Q2 2013. 31 funds tracked by Wall St. Rank hold GMO as of Q3 2020.

  • Barclays reported no remaining General Moly, Inc. position as of Q3 2020 after selling out during the quarter.
  • Barclays sold 800 General Moly, Inc. shares in Q3 2020.
  • Barclays first reported a position in General Moly, Inc. in Q2 2013 and held it in 8 quarters.
  • Barclays's General Moly, Inc. position peaked at $21K in Q2 2013.
  • 31 funds tracked by Wall St. Rank held General Moly, Inc. as of Q3 2020.

Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.